Tanja Gmeiner Stopar

Summary

Affiliation: University Medical Centre
Country: Slovenia

Publications

  1. ncbi (99m)Tc-rituximab radiolabelled by photo-activation: a new non-Hodgkin's lymphoma imaging agent
    T Gmeiner Stopar
    Department for Nuclear Medicine, University Medical Centre Ljubljana, Zaloska 7, 1525 Ljubljana Slovenia
    Eur J Nucl Med Mol Imaging 33:53-9. 2006
  2. ncbi 99mTc-labelled rituximab, a new non-Hodgkin's lymphoma imaging agent: first clinical experience
    Tanja Gmeiner Stopar
    Department for Nuclear Medicine, University Medical Centre Ljubljana, Slovenia
    Nucl Med Commun 29:1059-65. 2008
  3. ncbi Adsorption of radiopharmaceuticals to syringes: setting up a reliable protocol for its assessment
    Tanja Gmeiner Stopar
    Department for Nuclear Medicine, University Medical Centre Ljubljana, Slovenia
    Nucl Med Commun 28:951-5. 2007
  4. ncbi Influence of radiation source geometry on determination of (111)In and (90)Y activity of radiopharmaceuticals
    Petra Kolenc Peitl
    Department for Nuclear Medicine, University Medical Centre Ljubljana, Zaloska bUniversity of Ljubljana, Faculty of Pharmacy, Askerceva, 1000 Ljubljana, Slovenia
    Nucl Med Commun 30:807-14. 2009
  5. ncbi 49A/G and CT60 polymorphisms of the cytotoxic T-lymphocyte-associated antigen 4 gene associated with autoimmune thyroid disease
    Ajda Bicek
    University Medical Centre Ljubljana, Department of Nuclear Medicine, Zaloska cesta 7, SI 1525 Ljubljana, Slovenia
    Hum Immunol 70:820-4. 2009

Collaborators

  • Stephen Mather
  • Ajda Bicek
  • Petra Kolenc Peitl
  • Sergej Hojker
  • Aljaz Socan
  • Tanja Gmeiner Stopar
  • Slavko Pecar
  • Petra Tomse
  • Marko Kroselj
  • Jure Fettich
  • Irena Mlinaric-Rascan
  • Samo Zver

Detail Information

Publications5

  1. ncbi (99m)Tc-rituximab radiolabelled by photo-activation: a new non-Hodgkin's lymphoma imaging agent
    T Gmeiner Stopar
    Department for Nuclear Medicine, University Medical Centre Ljubljana, Zaloska 7, 1525 Ljubljana Slovenia
    Eur J Nucl Med Mol Imaging 33:53-9. 2006
    ....
  2. ncbi 99mTc-labelled rituximab, a new non-Hodgkin's lymphoma imaging agent: first clinical experience
    Tanja Gmeiner Stopar
    Department for Nuclear Medicine, University Medical Centre Ljubljana, Slovenia
    Nucl Med Commun 29:1059-65. 2008
    ....
  3. ncbi Adsorption of radiopharmaceuticals to syringes: setting up a reliable protocol for its assessment
    Tanja Gmeiner Stopar
    Department for Nuclear Medicine, University Medical Centre Ljubljana, Slovenia
    Nucl Med Commun 28:951-5. 2007
    ..The consequence of adsorption of a radiopharmaceutical and subsequent inadequate dosing can include an inappropriate diagnostic response in patients, an increase in the duration of investigation or treatment, and an increase in cost...
  4. ncbi Influence of radiation source geometry on determination of (111)In and (90)Y activity of radiopharmaceuticals
    Petra Kolenc Peitl
    Department for Nuclear Medicine, University Medical Centre Ljubljana, Zaloska bUniversity of Ljubljana, Faculty of Pharmacy, Askerceva, 1000 Ljubljana, Slovenia
    Nucl Med Commun 30:807-14. 2009
    ..Indium-111 (In) is used as a Y surrogate for imaging and dosimetry purposes. We aimed to investigate accuracy, geometry (vials and syringes) and volume dependencies for both radionuclides in several different radionuclide calibrators...
  5. ncbi 49A/G and CT60 polymorphisms of the cytotoxic T-lymphocyte-associated antigen 4 gene associated with autoimmune thyroid disease
    Ajda Bicek
    University Medical Centre Ljubljana, Department of Nuclear Medicine, Zaloska cesta 7, SI 1525 Ljubljana, Slovenia
    Hum Immunol 70:820-4. 2009
    ..Our results may therefore lend support to the hypothesis that humoral autoimmunity is correlated with 49A/G and CT60 polymorphisms of the CTLA-4 gene...